Fig. 8From: Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathwaysA schematic illustration demonstrated the inhibitory effect of cilostazol on RAGE-mediated oxidative stress, inflammation, adhesion and migration through RAGE/ERK/NF-κB pathways in VSMCs under hyperglycemic conditionsBack to article page